Patent priority date issues under the Raising the Bar regime
We consider the Federal Court’s guidance in the ToolGen CRISPR debate on the higher standard for claiming priority under the Raising the Bar regime.
The Prescription addresses legal developments and trends in healthcare and life sciences in Australia.
We consider the Federal Court’s guidance in the ToolGen CRISPR debate on the higher standard for claiming priority under the Raising the Bar regime.
We discuss the US Supreme Court’s decision regarding claims to broad classes of antibodies defined by function and its implications for Australia.
We unpick the High Court’s judgment regarding misleading or deceptive conduct in the context of comparative marketing.
We provide an update on the Special Commission of Inquiry into Healthcare Funding in NSW.
We consider the Australian Government’s proposal for a new aged care regulatory regime expected to commence on 1 July 2024.
We pprovide a recap on key changes to the aged care regulatory regime throughout the 2023 calendar year.